| 0 (0%) | 10-14 18:22 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 43.14 |
1-year : | 50.39 |
| Resists | First : | 36.93 |
Second : | 43.14 |
| Pivot price | 35.79  |
|||
| Supports | First : | 35.51 |
Second : | 34.63 |
| MAs | MA(5) : | 35.92 |
MA(20) : | 35.83 |
| MA(100) : | 35.65 |
MA(250) : | 32.22 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 57.5 |
D(3) : | 61.9 |
| RSI | RSI(14): 50.6 |
|||
| 52-week | High : | 38 | Low : | 24.04 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RPRX ] has closed below upper band by 39.3%. Bollinger Bands are 11.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 36.18 - 36.38 | 36.38 - 36.57 |
| Low: | 34.96 - 35.23 | 35.23 - 35.47 |
| Close: | 35.61 - 36 | 36 - 36.36 |
Tue, 14 Oct 2025
Callan Family Office LLC Buys Shares of 16,418 Royalty Pharma PLC $RPRX - MarketBeat
Mon, 13 Oct 2025
Royalty Pharma (RPRX) Valuation: Is There More Upside After This Year’s 40% Rally? - Yahoo Finance
Mon, 13 Oct 2025
Can RPRX stock weather global recession - Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Mon, 13 Oct 2025
Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 23.59% Upside Potential in the Biotech Royalty Space - DirectorsTalk Interviews
Mon, 13 Oct 2025
Can RPRX stock reach $100 price target - Dip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
Sun, 12 Oct 2025
Royalty Pharma PLC $RPRX Shares Sold by Board of the Pension Protection Fund - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 432 (M) |
| Shares Float | 380 (M) |
| Held by Insiders | 8.7 (%) |
| Held by Institutions | 82.6 (%) |
| Shares Short | 12,870 (K) |
| Shares Short P.Month | 16,620 (K) |
| EPS | 2.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.68 |
| Profit Margin | 44.2 % |
| Operating Margin | 38.8 % |
| Return on Assets (ttm) | 6.4 % |
| Return on Equity (ttm) | 17.2 % |
| Qtrly Rev. Growth | 7.6 % |
| Gross Profit (p.s.) | 6.24 |
| Sales Per Share | 5.34 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -68.6 % |
| Operating Cash Flow | 2,410 (M) |
| Levered Free Cash Flow | -747 (M) |
| PE Ratio | 15.72 |
| PEG Ratio | 0 |
| Price to Book value | 2.45 |
| Price to Sales | 6.73 |
| Price to Cash Flow | 6.45 |
| Dividend | 0.21 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|